Canosimibe

DB19723InvestigationalSmall molecule

Canosimibe is a small molecule drug. Canosimibe is under investigation in clinical trial NCT00729027 (Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary... Canosimibe has a monoisotopic molecular weight of 809.43 Da.

Formula / weight: C₄₄H₆₀FN₃O₁₀ · 809.973 g/mol (avg)
Code names: AVE-5530

Resolves to

Compound

UNII2GG0K1I5CICAS768394-99-6ChEMBLCHEMBL6068542ChEBI760450PubChem9875746

Structure

InChIKeyJGNXLPQJHVVQHB-GXPLPOFXSA-NSMILES

COC1=CC=C(C=C1)[C@@H]1[C@@H](CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N1C1=CC=C(CNC(=O)CCCCCCCCCCC(=O)NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C=C1

What you can answer from here — as of September 23, 2026

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Canosimibe, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account